How does Ozempic work? Ozempic and MedicGLP other GLP-1 receptor agonists have gained attention for their role in treating type 2 diabetes and promoting weight loss. These medications mimic a hormone that helps regulate blood sugar and appetite. While their benefits are clear, they also come with potential risks and side effects. How do GLP-1 drugs like Ozempic work? GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications that work by mimicking the natural GLP-1 hormone. This hormone is released by the gut in response to eating and has several effects that help regulate blood sugar levels, hunger, and slow digestion. Tirzepatide is a related drug that mimics GLP-1 as well as a hormone called a glucose-dependent insulinotropic polypeptide (GIP). Most GLP-1 drugs are administered by injection into the abdomen, thigh, or upper arm. How do GLP-1s help manage diabetes? For people with type 2 diabetes, controlling blood sugar levels is essential to preventing complications like nerve damage, kidney disease, and heart problems.

GLP-1 receptor agonists like semaglutide (Ozempic), liraglutide (Victoza), and Medic GLP Website tirzepatide (Mounjaro) help by increasing insulin secretion in response to meals, thereby lowering blood sugar levels. They also lower levels of glucagon, a hormone that raises blood sugar. GLP-1 drugs lower blood sugar only when it's high, unlike insulin, which works regardless of glucose levels. GLP-1 receptor agonists also reduce the likelihood of developing heart-related problems such as heart attacks or strokes. This is an important consideration because diabetes increases heart disease risk. How do GLP-1s support weight loss? One of the reasons GLP-1 receptor agonists have gained so much attention is their ability to help with weight loss. These medications slow down stomach emptying, keeping you feeling full longer. They also send signals to the brain that increase feelings of fullness, leading to reduced food intake. GLP-1s are typically prescribed at a higher dose for obesity than for diabetes. Liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound) are all FDA-approved for weight loss. (Image: https://impire.cz/upload/references/101/101_preview_fit_1000x10000.png)

In some studies, participants using GLP-1s have lost an average of 10% to 15% of their body weight over a year. The most effective GLP-1 medications can lead to weight loss of over 20% of body weight. This level of weight loss is significant because even a 5% to 10% reduction in body weight can improve metabolic health, lower blood pressure, and decrease the risk of conditions like fatty liver disease and obstructive sleep apnea. Like any medication, GLP-1 receptor agonists may cause side effects in some people. These side effects often improve as the body adjusts to the medication. To minimize them, doctors typically start with a low dose and gradually increase it over time. Other less common but possible side effects include headaches, increased heart rate, dizziness, and fatigue. Some individuals may also experience mild injection site reactions such as redness or itching. Dr. Chika Anekwe, Obesity Medicine Clinical Director at Massachusetts General Hospital Weight Center and instructor at Harvard Medical School, points out that a common misconception is that everyone experiences major side effects.

While GLP-1 drugs are generally considered safe, they do come with potential risks. Persistent nausea or vomiting can lead to dehydration, kidney problems, or malnutrition in some cases. People with serious gastrointestinal conditions, like gastroparesis or uncontrolled inflammatory bowel disease, Medic GLP Support should not take GLP-1 medications. And these medications are not considered safe for use during pregnancy or breastfeeding. Pancreatitis: Some studies suggest a possible link between GLP-1s and inflammation of the pancreas, though the risk appears to be low. Gallbladder problems: Some people develop gallstones or gallbladder inflammation while taking Medic GLP Website-1s. Thyroid tumors: Animal studies have raised concerns about a potential link between GLP-1s and thyroid tumors, but ongoing surveillance has not shown that this applies to humans. Muscle loss: Some reports suggest that rapid weight loss from GLP-1s may lead to a decrease in muscle mass. This is of particular concern for older adults, who may be at a higher risk for frailty and falls.